LDX 2.13% 4.8¢ lumos diagnostics holdings limited

Ann: Q4 FY24 Investor Presentation, page-6

  1. 992 Posts.
    lightbulb Created with Sketch. 136
    I though Paul gave very good insight and clarity around the process and current position with the product. People shouldn't have too much concern after his comments.

    No further capex for upcoming flu season and product quantity.

    Hologic announcement for phase 2 expected within 60 days? 20 months from Jan is September next year. Phase 1 and 2 should be complete by end of September 2024. Likely second payment $600K to be received by end of next quarter?

    Next 12 months is going to be focused on selling the current products, establishing the CLIA wavier testing, third phase of FFN, and ramping of the services with the new clients.

    Appears there is going to be some announcements coming with new services deals and other partners for Febridx to come.

 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.